| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 54.5956 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 54.5956. The average price that SDZ.SW shares were previous bought at was CHF 44.1701. The current market price is 23.6% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 149,756 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 122 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 122. The average price that IPN.PA shares were previous bought at was EUR 103.683. The current market price is 17.7% higher than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 38,855 compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 609.299 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 609.299. The average price that LONN.SW shares were previous bought at was CHF 606.416. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 228,372 compared to the previous valuation of |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 114.95 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 114.95. The average price that MRK.DE shares were previous bought at was EUR 115.858. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 79,762 compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 106.11 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 106.11. The average price that NOVN.SW shares were previous bought at was CHF 101.338. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 708,007 compared to the previous valuation of |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 44.8331 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 44.8331. The average price that NOVO-B.CO shares were previous bought at was DKK 63.2354. The current market price is -29.1% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 648,518 compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| NSIS-B.CO - | HOLD | 0 @ DKK 51.3201 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 51.3201. The average price that NSIS-B.CO shares were previous bought at was DKK 61.0647. The current market price is -16.0% lower than average price they were purchased at. The value of the holding in NSIS-B.CO has fallen by DKK 169,108 compared to the previous valuation of |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 62.5 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 62.5. The average price that ORNBV.HE shares were previous bought at was EUR 60.1932. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 69,213 compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 23.94 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 23.94. The average price that PHIA.AS shares were previous bought at was EUR 21.0294. The current market price is 13.8% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 192,675 compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 40.98 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 40.98. The average price that QIA.DE shares were previous bought at was EUR 42.5094. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 14,811 compared to the previous valuation of QIAGEN NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 50.8 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 50.8. The average price that REC.MI shares were previous bought at was EUR 53.4467. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 7,051 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 280.519 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 280.519. The average price that ROG.SW shares were previous bought at was CHF 281.464. The current market price is -0.3% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 593,579 compared to the previous valuation of |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 87.92 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 87.92. The average price that SAN.PA shares were previous bought at was EUR 88.9526. The current market price is -1.2% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 324,407 compared to the previous valuation of Sanofi SA however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 3.91546 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 3.91546. The average price that HLN.L shares were previous bought at was GBP 4.56586. The current market price is -14.2% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 4,464 compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| SECT-B.ST - | HOLD | 0 @ SEK 28.2783 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 28.2783. The average price that SECT-B.ST shares were previous bought at was SEK 29.0373. The current market price is -2.6% lower than average price they were purchased at. The value of the holding in SECT-B.ST has increased by SEK 5,123 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| SFZN.SW - | HOLD | 0 @ CHF 84.9959 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 84.9959. The average price that SFZN.SW shares were previous bought at was CHF 105.102. The current market price is -19.1% lower than average price they were purchased at. The value of the holding in SFZN.SW has fallen by CHF 807 compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 49.35 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 49.35. The average price that SHL.DE shares were previous bought at was EUR 47.9251. The current market price is 3.0% higher than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 67,953 compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 15.5302 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 15.5302. The average price that SN.L shares were previous bought at was GBP 12.7572. The current market price is 21.7% higher than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 61,050 compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 30.0377 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 30.0377. The average price that SOBI.ST shares were previous bought at was SEK 26.4967. The current market price is 13.4% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 24,480 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 240.337 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 240.337. The average price that SOON.SW shares were previous bought at was CHF 271.632. The current market price is -11.5% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 35,700 compared to the previous valuation of |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 239.8 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 239.8. The average price that SRT3.DE shares were previous bought at was EUR 215.217. The current market price is 11.4% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 37,292 compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 101.5 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 101.5. The average price that STMN.SW shares were previous bought at was CHF 113.693. The current market price is -10.7% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 340,283 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| TECN.SW - | HOLD | 0 @ CHF 160.404 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 160.404. The average price that TECN.SW shares were previous bought at was CHF 178.532. The current market price is -10.2% lower than average price they were purchased at. The value of the holding in TECN.SW has increased by CHF 5,609 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 220 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 220. The average price that TUB.BR shares were previous bought at was EUR 128.453. The current market price is 71.3% higher than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 31,601 compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 235.3 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 235.3. The average price that UCB.BR shares were previous bought at was EUR 162.822. The current market price is 44.5% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 426,870 compared to the previous valuation of UCB SA however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 62.366 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 62.366. The average price that ZEAL.CO shares were previous bought at was DKK 58.9926. The current market price is 5.7% higher than average price they were purchased at. The value of the holding in ZEAL.CO has increased by DKK 21,863 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 30.0985 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 30.0985. The average price that DEMANT.CO shares were previous bought at was DKK 35.6031. The current market price is -15.5% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 8,158 compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 64.0109 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 64.0109. The average price that ALC.SW shares were previous bought at was CHF 77.6685. The current market price is -17.6% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 68,812 compared to the previous valuation of |
| ALK-B.CO - | HOLD | 0 @ DKK 28.4115 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 28.4115. The average price that ALK-B.CO shares were previous bought at was DKK 23.6007. The current market price is 20.4% higher than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 9,070 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| AMBU-B.CO - | HOLD | 0 @ DKK 13.938 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 13.938. The average price that AMBU-B.CO shares were previous bought at was DKK 13.8673. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in AMBU-B.CO has fallen by DKK 7,226 compared to the previous valuation of |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 14.99 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 14.99. The average price that AMP.MI shares were previous bought at was EUR 20.2713. The current market price is -26.1% lower than average price they were purchased at. The value of the holding in AMP.MI has fallen by EUR 19,140 compared to the previous valuation of Amplifon SpA |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 716.6 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 716.6. The average price that ARGX.BR shares were previous bought at was EUR 508.161. The current market price is 41.0% higher than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 109,279 compared to the previous valuation of Argenx SE however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 142.587 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 142.587. The average price that AZN.L shares were previous bought at was GBP 125.063. The current market price is 14.0% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 856,257 compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| BAVA.CO - | HOLD | 0 @ DKK 32.2006 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 32.2006. The average price that BAVA.CO shares were previous bought at was DKK 22.8997. The current market price is 40.6% higher than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 17,977 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 27.56 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 27.56. The average price that BAYN.DE shares were previous bought at was EUR 25.4056. The current market price is 8.5% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 48,030 compared to the previous valuation of Bayer AG however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 112 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 112. The average price that BIM.PA shares were previous bought at was EUR 119. The current market price is -5.9% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 28,783 compared to the previous valuation of BioMerieux |
| CAMX.ST - | HOLD | 0 @ SEK 56.6758 | SEK 0 | |
| COLO-B.CO - | HOLD | 0 @ DKK 79.4772 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 79.4772. The average price that COLO-B.CO shares were previous bought at was DKK 86.1309. The current market price is -7.7% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 49,299 compared to the previous valuation of |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.74502 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.74502. The average price that CTEC.L shares were previous bought at was GBP 3.26342. The current market price is -15.9% lower than average price they were purchased at. The value of the holding in CTEC.L has fallen by GBP 27,040 compared to the previous valuation of ConvaTec Group PLC |
| ABVX.PA - Abivax SA | HOLD | 0 @ EUR 83.7 | EUR 0 | |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 76.44 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 76.44. The average price that DIA.MI shares were previous bought at was EUR 95.1491. The current market price is -19.7% lower than average price they were purchased at. The value of the holding in DIA.MI has fallen by EUR 8,831 compared to the previous valuation of DiaSorin SpA |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 208.9 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 208.9. The average price that DIM.PA shares were previous bought at was EUR 198.449. The current market price is 5.3% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 2,348 compared to the previous valuation of Sartorius Stedim Biotech |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 318.3 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 318.3. The average price that EL.PA shares were previous bought at was EUR 248.629. The current market price is 28.0% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 106,440 compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 60.6 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 60.6. The average price that ERF.PA shares were previous bought at was EUR 57.9209. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 20,141 compared to the previous valuation of Eurofins Scientific SE |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 46.82 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 46.82. The average price that FME.DE shares were previous bought at was EUR 47.8642. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 29,456 compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 50.56 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 50.56. The average price that FRE.DE shares were previous bought at was EUR 42.5137. The current market price is 18.9% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 147,121 compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 158.034 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 158.034. The average price that GALD.SW shares were previous bought at was CHF 119.169. The current market price is 32.6% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 196,877 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| GETI-B.ST - | HOLD | 0 @ SEK 20.6085 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 20.6085. The average price that GETI-B.ST shares were previous bought at was SEK 17.2685. The current market price is 19.3% higher than average price they were purchased at. The value of the holding in GETI-B.ST has increased by SEK 13,751 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 248.902 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 248.902. The average price that GMAB.CO shares were previous bought at was DKK 186.369. The current market price is 33.6% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 31,156 compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 11.425 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 11.425. The average price that GRF.MC shares were previous bought at was EUR 10.3964. The current market price is 9.9% higher than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 1,253 compared to the previous valuation of Grifols SA however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 19.8895 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 19.8895. The average price that GSK.L shares were previous bought at was GBP 16.9988. The current market price is 17.0% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 2,019,683 compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 20.6955 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 20.6955. The average price that HIK.L shares were previous bought at was GBP 23.9671. The current market price is -13.7% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 32,324 compared to the previous valuation of however if the holding was sold on 2025-10-29 this would crystalise an overall loss. |